Also, it has been reported that miR-125a-p5 acts as an NFκB inhibitor upon the Toll-like receptor signaling (TLR) pathway’s activation, inhibiting erythroid differentiation in leukemia [30]. This evidence concerns the gene NFKB1 and leukemia.